Efficacy and safety of ertugliflozin in subjects with type 2 diabetes mellitus inadequately controlled on the dual combination of metformin and sitagliptin: the VERTIS SITA2 trial

被引：0
|
作者：
Lauring, B. [1 ]
Eldor, R. [1 ]
Liu, J. [2 ]
Dagogo-Jack, S. [3 ]
Amorin, G. [4 ]
Johnson, J. [1 ]
Hille, D. [5 ]
Huyck, S. [1 ]
Golm, G. [1 ]
Terra, S. [6 ]
Mancuso, J. [7 ]
Engel, S. S. [1 ]
机构：
[1] Merck & Co Inc, Rahway, NJ 07065 USA
[2] Merck & Co Inc, Chicago, IL USA
[3] Univ Tennessee, Ctr Hlth Sci, Memphis, TN 38163 USA
[4] MSD Argentina, Buenos Aires, DF, Argentina
[5] Merck & Co Inc, Kenilworth, NJ USA
[6] Pfizer Inc, Andover, MA USA
[7] Pfizer Inc, Groton, CT 06340 USA
来源：
DIABETOLOGIA | 2016年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
181
引用
收藏
页码：S93 / S93
页数：1
相关论文
共 50 条
  • [21] SAFETY AND EFFICACY OF SITAGLIPTIN COMPARED WITH GLIMEPIRIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS INADEQUATELY CONTROLLED WITH METFORMIN MONOTHERAPY
    Abrar, Amjad
    Khan, Shimal
    Rehman, Mehboob Ur
    Jan, Tehmina
    Faisal, Muhammad
    GOMAL JOURNAL OF MEDICAL SCIENCES, 2013, 11 (01): : 3 - 7
  • [22] Safety and efficacy of ertugliflozin compared with glimepiride after 104 weeks in patients with type 2 diabetes inadequately controlled on metformin: VERTIS SU extension
    Hollander, P.
    Liu, J.
    Hill, J.
    Johnson, J.
    Jiang, Z. W.
    Wang, D.
    Golm, G.
    Huyck, S.
    Terra, S.
    Mancuso, J. P.
    Engel, S. S.
    Lauring, B.
    DIABETOLOGIA, 2018, 61 : S304 - S304
  • [23] Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized Study
    Sam Miller
    Tania Krumins
    Haojin Zhou
    Susan Huyck
    Jeremy Johnson
    Gregory Golm
    Steven G. Terra
    James P. Mancuso
    Samuel S. Engel
    Brett Lauring
    Diabetes Therapy, 2018, 9 : 253 - 268
  • [24] Efficacy and Safety of Ertugliflozin in Patients With Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy: a Substudy of VERTIS CV
    Strojek, Krzysztof
    Pandey, A. Shekhar
    Dell, Vanessa
    Sisson, Melanie
    Wang, Shuai
    Huyck, Susan
    Liu, Jie
    Gantz, Ira
    DIABETES THERAPY, 2021, 12 (04) : 1175 - 1192
  • [25] Efficacy and Safety of Ertugliflozin in Patients With Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy: a Substudy of VERTIS CV
    Krzysztof Strojek
    A. Shekhar Pandey
    Vanessa Dell
    Melanie Sisson
    Shuai Wang
    Susan Huyck
    Jie Liu
    Ira Gantz
    Diabetes Therapy, 2021, 12 : 1175 - 1192
  • [26] Ertugliflozin and Sitagliptin Co-initiation in Patients with Type 2 Diabetes: The VERTIS SITA Randomized Study
    Miller, Sam
    Krumins, Tania
    Zhou, Haojin
    Huyck, Susan
    Johnson, Jeremy
    Golm, Gregory
    Terra, Steven G.
    Mancuso, James P.
    Engel, Samuel S.
    Lauring, Brett
    DIABETES THERAPY, 2018, 9 (01) : 253 - 268
  • [27] Results of VERTIS SU extension study: safety and efficacy of ertugliflozin treatment over 104 weeks compared to glimepiride in patients with type 2 diabetes mellitus inadequately controlled on metformin
    Hollander, Priscilla
    Hill, Julie
    Johnson, Jeremy
    Jiang, Zhi Wei
    Golm, Gregory
    Huyck, Susan
    Terra, Steven G.
    Mancuso, James P.
    Engel, Samuel S.
    Lauring, Brett
    Liu, Jie
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (08) : 1335 - 1343
  • [28] Efficacy and safety of ipragliflozin as an add-on therapy to sitagliptin and metformin in Korean patients with inadequately controlled type 2 diabetes mellitus: A randomized controlled trial
    Han, Kyung-Ah
    Chon, Suk
    Chung, Choon Hee
    Lim, Soo
    Lee, Kwan-Woo
    Baik, SeiHyun
    Jung, Chang Hee
    Kim, Dong-Sun
    Park, Kyong Soo
    Yoon, Kun-Ho
    Lee, In-Kyu
    Cha, Bong-Soo
    Sakatani, Taishi
    Park, Sumi
    Lee, Moon-Kyu
    DIABETES OBESITY & METABOLISM, 2018, 20 (10): : 2408 - 2415
  • [29] Randomized trial assessing the safety and efficacy of sitagliptin in Chinese patients with type 2 diabetes mellitus inadequately controlled on sulfonylurea alone or combined with metformin
    Ba, Jianming
    Han, Ping
    Yuan, Guoyue
    Mo, Zhaohui
    Pan, Changyu
    Wu, Fan
    Xu, Lei
    Hanson, Mary E.
    Engel, Samuel S.
    Shankar, R. Ravi
    JOURNAL OF DIABETES, 2017, 9 (07) : 667 - 676
  • [30] Safety and Efficacy of Ertugliflozin plus Sitagliptin vs. Either Treatment Alone after 52 Weeks in Subjects with T2DM Inadequately Controlled on Metformin: VERTIS FACTORIAL Trial Extension
    Pratley, Richard E.
    Raji, Annaswamy
    Eldor, Roy
    Sunga, Sheila
    Qiu, Yanping
    Johnson, Jeremy
    Huyck, Susan
    Golm, Gregory
    Terra, Steven G.
    Mancuso, James P.
    Engel, Samuel S.
    Lauring, Brett
    DIABETES, 2017, 66 : A34 - A34
12345